VERTEX PHARMACEUTICALS INC (VRTX) Institutional Ownership Changes & 13F Activity

VERTEX PHARMACEUTICALS INC (VRTX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC, Sequoia Financial Advisors, Tweedy, Browne Co All Funds (US), Torray Fund, and ARK Invest.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2014Renaissance Technologies LLCBuy172,944312,164$22,076
Q1 2014Torray FundBuy22,11776,397$5,403
Q4 2013Torray FundBuy8,31054,280$4,033
Q3 2013Renaissance Technologies LLCBuy139,220139,220$10,556
Q3 2013Torray FundBuy59845,970$3,485
Q2 2013Torray FundBuy45,37245,372$3,632

Frequently asked questions about VRTX activity

  • Which institutional owners are buying VRTX?

    Institutional owners buying VRTX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in VRTX activity?

    "Buy" means an investor increased their reported position in VRTX compared to the prior reporting period. This reflects growing exposure to VERTEX PHARMACEUTICALS INC (VRTX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in VRTX increasing?

    Institutional interest in VRTX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related VRTX Institutional Insights